Levetiracetam to improve recovery after brain bleed
Part of Brain & nervous system clinical trials.
This trial tests whether giving a drug called levetiracetam (which is normally used to prevent seizures) soon after a type of stroke called a brain bleed (intracerebral haemorrhage) can improve recovery. It is a randomised, double-blind trial, meaning half the participants get the drug and half get a placebo (a dummy pill), and neither you nor the doctors know which one you are taking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your stroke was caused by bleeding inside the brain (not by an injury, a tumor, or a blocked artery).
- Your stroke symptoms started within the last 24 hours.
- Your stroke is not too severe (based on a standard neurological exam).
- You have not had seizures or taken anti-seizure medication before.
- You do not have severe kidney problems, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.
This trial tests whether giving the seizure medication levetiracetam early can prevent or treat brain problems in people with septic shock. Septic shock is a life-threatening infection that can affect the brain, and this study aims to see if this drug helps protect brain function.
This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This trial tests whether taking levetiracetam (a medicine used to prevent seizures) around the time of brain tumor surgery can reduce the chance of postoperative seizures. It may help people who are having surgery in the brain area where seizures are a known risk.
Hear when a new Spontaneous Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.